Kaleido Biosciences Inc. (KLDO) OTC MARKETS
$0 - (-)
Market Cap: -
As of 04/22/24 12:00 AM EDT. Market closed.
Kaleido Biosciences Inc. (KLDO)
OTC MARKETS
$0
- (-)
Market Cap: -
As of 04/22/24 12:00 AM EDT. Market closed.
Add to Portfolio
the next breakthrough microbiome company from flagship venturelabs – the innovation foundry of flagship ventures – is ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$9.92M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full Time Employees
167
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$9.92M
URL
Address
.
PRICE CHART FOR KALEIDO BIOSCIENCES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.42
Previous Close
$0
Days Range
- - -
52 week range
- - -
Volume
1,250
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
42,622,559
Open
$0.42
Previous Close
$0
Days Range
- - -
52 week range
- - -
Volume
1,250
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
42,622,559
FINANCIAL STATEMENTS FOR KALEIDO BIOSCIENCES INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR KALEIDO BIOSCIENCES INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| van Hylckama Vlieg Johan | Chief Scientific Officer | Feb 28, 2022 | Option Exercise | $1.49 | 2,087 | 3,110 | 4,620 | Mar 02, 2022, 04:09 PM |
| Korn Jerald | COO & General Counsel | Feb 28, 2022 | Option Exercise | $1.49 | 2,046 | 3,049 | 4,517 | Mar 02, 2022, 04:05 PM |
| Menichella Daniel L | Chief Executive Officer | Feb 08, 2021 | Buy | $11.50 | 20,000 | 230,000 | 20,000 | Feb 26, 2021, 05:12 PM |
| Flagship Ventures Fund IV General Partner LLC | 10% Owner | Feb 08, 2021 | Buy | $11.50 | 215,000 | 2,472,500 | 2,982,639 | Feb 10, 2021, 05:30 PM |
| Flagship Ventures Fund IV General Partner LLC | 10% Owner | Jun 04, 2020 | Buy | $7.50 | 2,000,000 | 15,000,000 | 2,910,972 | Jun 08, 2020, 04:46 PM |
| MELAS KYRIAZI THEO | Director | Jun 04, 2020 | Buy | $7.50 | 33,333 | 249,998 | 33,333 | Jun 05, 2020, 04:06 PM |
| Flagship Ventures Fund V General Partner LLC | Director | Mar 04, 2019 | Buy | $15.00 | 933,333 | 13,999,995 | 6,560,523 | Mar 06, 2019, 04:45 PM |
| BONNEY MICHAEL W | Executive Chair | Feb 28, 2019 | Buy | $13.98 | 71,520 | 999,492 | 1,008,523 | Mar 04, 2019, 08:13 PM |
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| van Hylckama Vlieg Johan | Chief Scientific Officer | 02/28/2022 | 3,110 |
| Korn Jerald | COO & General Counsel | 02/28/2022 | 3,049 |
| Menichella Daniel L | Chief Executive Officer | 02/08/2021 | 230,000 |
| Flagship Ventures Fund IV General Partner LLC | 10% Owner | 02/08/2021 | 2,472,500 |
| Flagship Ventures Fund IV General Partner LLC | 10% Owner | 06/04/2020 | 15,000,000 |
| MELAS KYRIAZI THEO | Director | 06/04/2020 | 249,998 |
| Flagship Ventures Fund V General Partner LLC | Director | 03/04/2019 | 13,999,995 |
| BONNEY MICHAEL W | Executive Chair | 02/28/2019 | 999,492 |
BUYBACK ANNOUNCEMENT(S) FOR KALEIDO BIOSCIENCES INC
LOADING...